α Cardiac Actin Antibody [J1E19]

Catalog No.: F4394

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:100-1:200
    Application
    WB, IHC, IF, ELISA
    Source
    Mouse Monoclonal Antibody
    Reactivity
    Mouse, Rat, Human, Bovine, Chicken
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    42 kDa

    Datasheet & SDS

    生物学的記述

    Specificity
    α Cardiac Actin Antibody [J1E19] detects endogenous levels of total α Cardiac Actin protein.
    Clone
    J1E19
    Synonym(s)
    Actin, alpha cardiac muscle 1, Alpha-cardiac actin, Actin, alpha cardiac muscle 1, intermediate form, ACTC1, ACTC
    Background
    α‑Cardiac actin, encoded by ACTC1, is the predominant sarcomeric actin isoform in developing and adult heart muscle and forms the core of thin filaments in cardiac myofibrils, where it organizes with myosin, tropomyosin, and the cardiac troponin complex to generate force during excitation–contraction coupling. The protein belongs to the α‑actin subgroup of the actin family and shares high overall sequence conservation with other muscle and nonmuscle actins, but the N‑terminal region carries isoform-specific residues that influence interactions with myosin heads, actin-binding proteins, and Z‑line components, and this region constitutes a major antigenic and regulatory interface in cardiac myocytes. Polymerization of α‑cardiac actin from globular (G‑actin) to filamentous (F‑actin) form generates the helical thin filaments that extend from Z‑discs toward the sarcomere center and provide the scaffold for myosin cross‑bridge cycling; within this context, α‑cardiac actin interacts with β‑myosin heavy chain and the Ca²⁺‑regulated troponin–tropomyosin complex so that small changes in actin conformation or binding energetics translate into altered Ca²⁺ sensitivity and maximal contractile force. Allosteric coupling within the actin filament allows amino-acid substitutions located away from direct myosin or regulatory protein contact sites to modify long‑range dynamics and thereby shift the balance between calcium sensitivity and force-generation pathways, and pathogenic ACTC1 variants such as T126I and S271F exemplify how altered actin allostery can drive either hypo‑contractile or hyper‑contractile phenotypes at the sarcomere level. α‑Cardiac actin accounts for the majority of myofibrillar actin in human donor hearts and represents the dominant sarcomeric isoform in embryonic heart and early skeletal muscle, while in the mature human heart it coexists with smaller amounts of α‑skeletal actin whose expression increases in pressure overload and hypertrophic remodeling. The ACTC1 gene participates in Rho–SRF–MRTF–regulated transcriptional networks that coordinate cytoskeletal gene expression with mechanical load, and α‑cardiac actin treadmilling influences the nucleo–cytoplasmic shuttling of myocardin‑related transcription factors, linking sarcomeric actin dynamics to adaptive changes in cardiomyocyte gene programs during growth and stress. Germline ACTC1 mutations associate with familial hypertrophic and dilated cardiomyopathies and with structural defects such as atrial septal defect and left ventricular noncompaction, where altered interactions between α‑cardiac actin and β‑myosin or the troponin–tropomyosin regulatory complex result in changes in contractile force, Ca²⁺ responsiveness, and ventricular geometry that can manifest as systolic or diastolic dysfunction.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください